Neil Korman, MD, PhD
- Director, Clinical Trials Unit, UH Cleveland Medical Center
- Director, Murdough Family Center for Psoriasis, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
- Specialty: Dermatology
- Call: 216-844-8200
Biography: Neil Korman, MD, PhD
Expertise
Certifications & Memberships
- Clinical and Laboratory Dermatological Immunology - American Board of Dermatology
- Dermatology - American Board of Dermatology
Education
Fellowship | Dermatology
Dermatology - Clinical Center At The National Institutes Of Health (1987 - 1990)
Residency | Dermatology
Dermatology - University Hospitals Of Cleveland (1985 - 1987)
Internship | Internal Medicine
Internal Medicine - University Hospitals Of Cleveland (1984 - 1985)
Medical Education
Case Western Reserve University School Of Medicine (1984)
Other Education
Case Western Reserve University (1982)
Other Education
Suny Stony Brook University (1977)
Undergraduate
Suny Stony Brook University (1976)
About
Neil Korman, MD, PhD, joined University Hospitals’ Department of Dermatology in 1990. He serves as Director of the Regional Center for Immunobullous Disease, University Hospitals Dermatology Clinical Trials Unit and Translational Research Core at Case Western Reserve University’s Skin Disease Research Center. Dr. Korman earned both his MD and PhD from Case Western Reserve University. He completed an internship and residency at University Hospitals and a research fellowship at the Dermatology Branch of the National Cancer Institute at the National Institutes of Health.
Dr. Korman has been recognized by U.S. News and World Report as a Best Doctor consecutively since 2011. He is a also a Distinguished Physician at University Hospitals and has received several other honors and awards throughout his career.
Dr. Korman’s clinical expertise is in complex medical dermatology, including autoimmune blistering diseases, psoriasis, hidradenitis suppurativa and atopic dermatitis. Heavily focused on clinical research, he has been involved in studies of psoriasis, atopic dermatitis, alopecia areata and hidradenitis suppurativa, among dermatological conditions. With more than 25 years of experience in clinical research, Dr. Korman has performed more than 100 phase 1 – 4 psoriasis clinical trials, including studies evaluating all the major biologic agents approved for treating psoriasis. He has also served as a co-investigator in several translational mechanism of action studies in patients with psoriasis.
Research & Publications
Research Links
PubMed
View Research
Research Interests
Psoriasis research, Bullous disease research, Translational research
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Neil Korman did not disclose any Outside Relationships with Industry.